Latest Balance Sheet News

Great Western Exploration Limited reported a $191,000 net cash outflow from operations in the December quarter but bolstered its cash reserves to $4.74 million through a $3.6 million capital raise, maintaining a solid financial footing for ongoing exploration.

KMD Brands reports improving sales in direct-to-consumer channels for FY25’s first five months, offset by ongoing wholesale challenges and a forecasted dip in EBITDA.

Peregrine Gold secures a significant $1 million commitment from its largest shareholder, Yandal Investments, strengthening its entitlement offer ahead of the project sale to Capricorn Metals.

Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.

Vonex Limited reports solid operational improvements and customer satisfaction in Q2 FY25, while endorsing Maxo Telecommunications’ takeover offer and planning a $13 million capital raise to manage debt.

Investigator Resources Limited has postponed the Definitive Feasibility Study (DFS) for its Paris Silver Project to mid-2025, citing rising costs and the need for further optimisation. Meanwhile, exploration drilling continues and asset sales bolster the company’s cash position to $2.7 million.

Santos delivered a robust Q4 2024 with over US$1.4 billion in sales revenue and strong free cash flow, while progressing key LNG projects and expanding its decarbonisation initiatives.

Horizon Gold advances its Gum Creek Gold Project with ongoing diamond drilling and a major upcoming RC drilling campaign aimed at upgrading its 2.14 million ounce gold resource. The company also strengthens its balance sheet following a strategic share sale.

Westgold Resources Limited achieved record gold production of 80,886 ounces in Q2 FY25, driving a robust net mine cash flow of $45 million and securing a $200 million corporate facility to fuel growth.

Peregrine Gold Limited has agreed to sell its Deadman Flat and Perry Creek Project to Capricorn Metals Ltd for A$1.5 million in shares, while maintaining upside through royalties and milestone payments. This deal strengthens Peregrine’s balance sheet and accelerates its focus on the Tin Can Trend exploration.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.